|
On 20-jan-2023, abbott point of care was contacted by a customer regarding i-stat cg8+ cartridges that yielded a suspected discrepant hematocrit results on an 88 year old male patient with a ruptured triple a.There was no additional patient information at the time of this report.Return product is not available for investigation.Method: i-stat, date: (b)(6) 2023 collected: ni, tested: 22:58, hb(g/dl): 6.5, hct(%pcv): 19.0, sample: arterial #1; method: i-stat, date: (b)(6) 2023, collected: ni, tested: 02:05, hb(g/dl): 5.1, hct(%pcv): 15.0, sample: arterial #2; method: gem, date: (b)(6) 2023, collected: 02:24, tested: 02:36, hb(g/dl): 11.6, hct(%pcv): n/a, sample: arterial #3; method: sysmex , date: (b)(6) 2023, collected: 02:24,tested: 02:37, hb(g/dl): 11.3, hct(%pcv): 32.9, sample: arterial #3.The patient was transfused 4 rbc and 1 ffp prior to surgery.Customer reports the units were not ordered based on the i-stat results, orders were in before i-stat testing took place.Transfusion time spanned from (b)(6) 2023 at 21:46 to (b)(6) 2023 at 00:39 with a total of 6 rbcs and 1 ffp.Patient given rbc units "active bleeding," and ffp "inr>2.0." at this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The investigation is underway.
|